-
1 Comment
Dongwha Pharm.Co.,Ltd is currently in a long term downtrend where the price is trading 4.6% below its 200 day moving average.
From a valuation standpoint, the stock is 82.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Dongwha Pharm.Co.,Ltd's total revenue sank by 17.6% to $69B since the same quarter in the previous year.
Its net income has dropped by 2.3% to $8B since the same quarter in the previous year.
Finally, its free cash flow fell by 84.2% to $837M since the same quarter in the previous year.
Based on the above factors, Dongwha Pharm.Co.,Ltd gets an overall score of 1/5.
| Exchange | KO |
|---|---|
| CurrencyCode | KRW |
| ISIN | KR7000020008 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | 2.9% |
|---|---|
| Beta | 1.23 |
| Market Cap | 173B |
| PE Ratio | None |
| Target Price | 14000 |
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000020.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
